Alzheimer's disease and estrogen replacement therapy - Where are we now?

Acta Obstetricia et Gynecologica Scandinavica

Volumn 80, Issue 8, 2001, Pages 679-682

  Polo Kantola, P ^a   Erkkola, R ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Alzheimer's disease; Estrogen replacement therapy; Protective factors; Risk factors

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIOXIDANT; ESTROGEN;

ALZHEIMER DISEASE; BRAIN FUNCTION; DISEASE SEVERITY; DRUG RESEARCH; ESTROGEN THERAPY; FINLAND; HEALTH CARE COST; HUMAN; NOTE; PRIORITY JOURNAL;

ALZHEIMER DISEASE; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; RISK FACTORS;

EID: 0034878893     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0412.2001.080008679.x     Document Type: Note

References (34)

1. Estimated prevalence of Alzheimer's disease in the United States
2. A population-based study of dementia in 85 year-olds
3. Alzheimer's disease in women: Can estrogen play a protective role
4. The prevalence of dementia: A quantitative integration of the literature
5. Amyloid plaque core protein in Alzheimer's disease and Down syndrome
6. HRT and dementia
7. Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women
8. Effects of estrogen replacement therapy on PET cerebral blood flow and neuropsychological performance
9. Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks
10. The effect of short-term estrogen replacement therapy on cognition: A randomized, double-blind, cross-over trial in postmenopausal women
11. Estrogen deficiency and risk of Alzheimer's disease in women
12. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease
13. Estrogen actions in the central nervous system
14. Estradiol increases choline acetyltransferase activity in specific basal forebrain nuclei and projection areas of female rats
15. Effect of 5,7-dihydroxytryptamine, ovariectomy and gonadal steroids on serotonin receptor binding in rat brain
16. Ovarian hormones differentially influence immunoreactivity for dopamine betahydroxylase, choline acetyltransferase, and serotonin in the dorsolateral prefrontal cortex of adult rhesus monkeys
17. Modulation of brain dopamine transmission by sex steroids
18. Estradiol enhances learning and memory in a spatial memory task and effects levels of monoaminergic neurotransmitters
19. Estrogens and non-estrogenic ovarian influences combine to promote the recruitment and decrease the turnover of new neurons in the adult female canary brain
20. Estrogen modulates neuronal bcl-xL expression and beta-amyloid-induced apoptosis: Relevance to Alzheimer's disease
21. Pulsatility index in internal carotid artery in relation to transdermal oestradiol and time since menopause
22. Observations in a preliminary open trial of estradiol therapy for senile dementia-Alzheimer's type
23. In vivo effects by estrone sulfate on the central nervous system-senile dementia (Alzheimer's type)
24. Evaluation of estrogen treatment in female patients with dementia of the Alzheimer's type
25. An effect of conjugated estrogen to cognitive impairment in women with senile dementia-Alzheimer's type: A placebo-controlled double blind study
26. Estrogen therapy in postmenopausal women. Effects on cognitive function and dementia
27. Estrogen replacement therapy for treatment of mild to moderate Alzheimer Disease. A randomized controlled trial
28. Balancing between observational studies and randomized trials in prevention of coronary heart disease by estrogen replacement. HERS study was no revolution
29. The Heart and Estrogen/Progestin Replacement Study (HERS) in perspective - Results not surprising
30. Estrogen for Alzheimer's disease in women: Randomized, double-blind, placebo-controlled trial
31. Effects of estrogen replacement therapy on response to tacrine in patients with Alzheimer's disease
32. Plasma tacrine concentrations are significantly increased by concomitant hormone replacement therapy
33. Postmenopausal estrogen replacement therapy and risk of AD: A population-based study